🔎 Trials Near Me

Gara Jalqabaatti › Myeloma Baay’ee › Oregon › Portland

Qorannoo klinikaalii Myeloma Baay’ee Portland, OR keessatti

Qorannoo 13 Myeloma Baay’ee f Portland fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Portland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07391657

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 3
  • Oregon Health And Science University, Portland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07258511

Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment

Namoota walitti qabaa jiraQorannoo ilaalaa
  • OHSU Knight Cancer Institute, Portland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT06784167

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Providence Health & Services, Portland
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT02693535

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 2
  • Oregon Health and Science University, Portland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06297226

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Oregon Health and Science University /ID# 272282, Portland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06953960

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 1
  • Providence Portland Medical Center, Portland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT07075185

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Portland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT07764978

Immuno-PRISM (PRecision Intervention Smoldering Myeloma)

Namoota walitti qabaa jiraSadarkaa 2
  • Oregon Health & Science University, Portland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ado-2026 · NCT05469893

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Namoota walitti qabaa jiraSadarkaa 3
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • Providence Willamette Falls Medical Center, Oregon City · Miili 12 fagaatti
Umuriin hundi · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT05561387

Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 1/2
  • Oregon Health and Science University (OHSU) Marquam Hill Campus, Portland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Elb-2026 · NCT03761108

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Local Institution - 0016, Portland
Umuriin hundi · Saalaa hunda · Haaromfame 22-Ama-2026 · NCT06357754

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Oregon Health Sciences University, Portland
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 20-Ama-2026 · NCT05366881

Qorannoo Myeloma Baay’ee magaalota biroo keessatti

Qorannoo biroo Portland keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.